Editorial Board
Eric Rosenthal ScM (Johns Hopkins Medicine); PhD (Harvard Medical School); BA (Wesleyan University)
Senior Manager of Clinical Content, Myriad Genetic Laboratories, Inc., Salt Lake City, UT · United States
Editorial leadership for Journal of Breast Cancer Survival
Research interests
- Hereditary Cancer Genetics Genetic Testing Genetic Counseling
Biography
Publications:
- Cyclin: A protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division.
- A multifunctional Urechis caupo protein, PAPS synthetase, has both ATP sulfurylase and APS kinase activities.
- Developmental characterization of the gene for laminin alpha-chain in sea urchin embryos.
- Clinical significance of large rearrangements in BRCA1 and BRCA2.
- A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes.
- Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry.
- Exceptions to the Rule: Case Studies in the Prediction of Pathogenicity for Genetic Variants in Hereditary Cancer Genes.
- Increased Identification of Candidates for High-Risk Breast Cancer Screening Through Expanded Genetic Testing.
Considering JBCS for your work?
This journal is guided by Eric Rosenthal (Senior Manager of Clinical Content, Myriad Genetic Laboratories, Inc., Salt Lake City, UT) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.